Syndax Pharmaceuticals (SNDX) Net Margin Growth (1y) (2016 - 2026)
Syndax Pharmaceuticals (SNDX) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
33,484.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
33,484.00 |
| Dec 31, 2025 |
107,588.00 |
| Sep 30, 2025 |
55,956.00 |
| Jun 30, 2025 |
177,515.00 |
| Dec 31, 2021 |
544,125.00 |
| Sep 30, 2021 |
519,265.00 |
| Jun 30, 2021 |
-154,011.00 |
| Mar 31, 2021 |
-328,496.00 |
| Dec 31, 2020 |
-168,579.00 |
| Sep 30, 2020 |
-199,393.00 |
| Jun 30, 2020 |
-56,728.00 |
| Mar 31, 2020 |
-22,612.00 |
| Dec 31, 2019 |
127,105.00 |
| Sep 30, 2019 |
121,346.00 |
| Jun 30, 2019 |
95,488.00 |
| Mar 31, 2019 |
129,736.00 |
| Dec 31, 2018 |
-335,590.00 |
| Sep 30, 2018 |
35,088.00 |
| Jun 30, 2018 |
-43,588.00 |
| Mar 31, 2018 |
-85,061.00 |
